Be among the first to see HCP Horizon in action.
In this live session, we will introduce the platform and show how it helps teams move from fragmented signals to clear, structured insight drawn from real HCP conversation.
Watch the launch event
Market research is episodic and slow to refresh. Congress feedback is partial and time-lagged. Social listening lacks clinical depth and structure. Internal perspectives, even from MSLs, can miss what is happening externally.
Meanwhile, healthcare professionals are continuously sharing valuable perspectives online. The challenge is turning that conversation into something structured, meaningful, and usable.
Important shifts in HCP thinking are often missed, or seen too late.
Search for a product, trial, company, or topic and see how HCPs are discussing it. Refine by market, specialty, sub-indication, or time period. Generate a clear, structured view of the conversation without needing to read through thousands of individual posts.
HCP Horizon complements DOL Finder.
DOL Finder identifies which healthcare professionals are making an impact in the digital landscape. HCP Horizon reveals what the wider HCP community is thinking, and how that thinking is changing.
Together, they provide a more complete view of HCP influence and insight.
At CREATION.co, we’ve led the way in using data science to identify and profile healthcare professional Digital Opinion Leaders since we first introduced the concept in 2012.
Deciding how to identify, profile and engage DOLs is a process as unique as your own goals. So we work with you to define what’s most important in your particular DOL identification and profiling exercise.
Below is an illustration of 10 of our metrics to identify your DOLs.
10 ways to identify DOLs
To learn more visit our Digital Opinion Leader Mapping page
We have been helping pharmaceutical companies with their HCP engagement strategies for the past 20 years. Based on our experience and expertise, here are our top 3 ideas on how to best engage with your HCP Digital Opinion Leaders:
For the rest of our list, check out our HCP engagement strategies article.
Once you have identified your Digital Opinion Leaders, you need to consider how to engage effectively with them. However, before you start thinking about identifying DOLs, you need to put this into context with your long-term goals and think about what would make a Digital Opinion Leader for you. You need to consider:
If you start by answering these, and other strategic DOL questions, you will have a much clearer picture of what a perfect DOL would look like for your business.
Remember, there is no single set of metrics that defines DOL impact. Individual pharma companies should design goals that reflect outcomes aligned with their business objectives. As well as ensuring those objectives also align with the goals of the DOL and, in some cases, the patient community.
At CREATION.co, we spend time ensuring those objectives have been discussed and with a pre-qualified database of nearly 3 million global HCP social media profiles, we can adjust our metrics to ensure the DOLs we identify are the right ones to support your goals.
DOLs suitable for marketing or commercial teams might look different to those suitable for the medical teams. CREATION.co have therefore identified a subset of Digital Opinion Leaders – Digital Scientific Leaders (DSLs). DSLs are HCPs who possess all the qualities of a DOL but have a specific focus and influence in the scientific conversation within the therapy area.
DSLs are driving the discussion around latest study and trial data, testing and diagnosis, and mechanism of action of treatments. In other words, they have a natural inclination to lead and shape the scientific dialogue amongst their peers online. They usually have higher scientific credentials and use their media for peer learning, education, and collaboration.
To learn more, read our article about Medical Affairs: best practice for identifying online HCP thought leaders
DOLs are already regulated, in the sense that their behaviour as professionals is governed by their respective professional bodies. In the UK, for example, the General Medical Council (GMC), which governs medical doctors, has provided guidance for doctors on their use of social media since 2013. While controversial among some doctors, the guidance forbids doctors from anonymity on social media.
Furthermore, and relevant to the role of DOLs, the GMC guidance requires doctors to declare any commercial or financial interests in pharmaceutical companies: “When you post material online, you should be open about any conflict of interest and declare any financial or commercial interests in healthcare organisations or pharmaceutical and biomedical companies.”
02.04.2026 | Webinars
What Online HCP Conversations in Lung Cancer Tell Us About 2026
19.02.2026 | Article
In the age of social media, influence extends beyond borders...
By Jessica Fernandes
19.02.2026 | Article
Digital channels have become central to professional discourse, peer-to-peer exchange and...
By Bernard Groen
19.02.2026 | Article
Trust is paramount and when it comes to influencing medical professional...
By Katie Kennedy
19.02.2026 | Article
As the healthcare landscape continues to evolve, Digital Opinion Leaders have emerged...
By Katie Kennedy
22.01.2026 | Article
How DOL Finder 2.0 changes the game
By Katie Kennedy